Fundraising FoxTachyon Ventures — Full Portfolio
18 tracked investments · listed companies and verified rows first
Absci uses an AI-based drug creation platform combined with wet lab validation to design biologic therapeutics such as antibodies from scratch.
AI & Machine LearningBiotechDeep TechPortland, US
Sean McClain(Founder)inPhil Barish(Executive Officer)inZachariah Jonasson(Chief Financial Officer and Chief Business Officer)Shelby Walker(Chief Legal Officer)inRansi Somaratne(Chief Medical Officer)Andreas Busch(Chief Innovation Officer)in
Co-investorsConvergent VenturesDas & Co.IKJ CapitalOregon Venture FundPhoenix Venture PartnersTau Ventures+6 more
AI Proteins designs engineered miniproteins for drug discovery and development in the biopharmaceutical industry.
AI & Machine LearningBiotechDeep TechAndover, US
Chris Bahl(Executive Officer, Director)inDominique Verhelle(Director)Bill McKee(Director)Julia Novina(Executive Officer)Marc A. Cohen(Executive Officer, Director)inGeoff Meyerson(Director)
Co-investorsMission BiocapitalCobro Ventures
Altay Therapeutics develops small molecule inhibitors targeting transcription factors to treat serious diseases including facioscapulohumeral muscular dystrophy and cancer.
BiotechDigital HealthHealthtechMedical DevicesSan Francisco, US
Ali Ozes(Founder)inOsman Ozes(Founder)inJAMES BREITMEYER(Executive Officer, Director)ERIC BJERKHOLT(Director)MIKE GREY(Director)ESTER SKLARSKY(Director)
Co-investorsCreative Destruction Lab (CDL)Jude GomilaY CombinatorFshd Global Research Foundation
Axonis Therapeutics is a biotechnology company developing small-molecule medicines that target KCC2, a mediator of inhibition in the brain, to treat neurological disorders such as epilepsy and pain.
BiotechDeep TechBoston, US
Shane V. Hegarty(Chief Scientific Officer & Co-Founder)inJoanna Stanicka(Chief Executive Officer, President & Co-Founder)inJeff Imbaro(Chief Operating Officer)inTiasha Shafiq(Chief of Staff)in
BoardCorey . Goodman(Director)inJonathan Leff(Director)in
Co-investorsSofinnova VenturesvenBio PartnersMRL Ventures FundCivilization Ventures Management, LlcCreative Destruction Lab (CDL)Hatteras Venture Partners+8 more
BiotechBerkeley, US
Genine Winslow(Founder)inRan Geng(Director)Winnie Wan(Director)
Co-investorsBerkeley SkyDeck FundFuture Planet CapitalSolasta Ventures
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inKevin Kalish(COO)inMarcie Glicksman(VP Biology)inWilliam Gormley(CMO)Jason Camm(Director)Kasper Roet(Director)in
Co-investors20/20 HealthCare Partners LLCDolby Family VenturesFlucas VenturesVU Venture PartnersAmgen VenturesBioverge+1 more
EpiBone engineers bone tissue from stem cells for regenerative medicine and clinical reconstruction, serving patients requiring bone grafts or craniofacial repair.
BiotechHealthtechMedical DevicesNew York, US
Nina Tandon(Co-Founder, CEO)inSarindr Bhumiratana(Co-Founder)inGordana Vunjak-Novakovic(Director)Elma Hawkins(Director)
BoardRobert Langer(Director)David Zhu(Director)in
Co-investorsBeresford VenturesCatalytic Impact FoundationEMV CapitalHackensack Meridian Health Bear's DenKendall Capital PartnersLifespan Vision Ventures+3 more
Haima Therapeutics is a pre-clinical stage biopharma company developing cell-inspired therapies for bleeding and blood-related diseases, with an initial focus on platelet-inspired treatments for active bleeding and bleeding risks from trauma, surgery, thrombocytopenia, and rare bleeding disorders.
BiotechMedical Devices
Anirban Sen Gupta(CTO)Michael Bruckman(CEO)inMatthew Neal(CMO)Christa Pawlowski(COO and EVP of R&D)Timothy Pelura(Executive Chair)
Co-investorsCWRU Technology Ventures
Mammoth Bio develops technology to read and write the code of life, operating in the biotechnology sector.
BiotechDeep TechMedical DevicesBrisbane, US
Jennifer Doudna(Founder)inTrevor Martin(Founder)inJanice Chen(Founder)inLucas Harrington(Founder)inAshley Tehranchi(Founder)in
BoardUrshit Parikh(Director)
Co-investors8VCBerkeley FrontierCalifornia Innovation FundDecheng CapitalForesite CapitalMayfield Fund+12 more
miRecule is a biotechnology company developing therapeutics, with programs focused on oncology.
BiotechHealthtechGaithersburg, US
Anthony D. Saleh(CEO)inDave Lemus(COO/CFO)in
Co-investorsAlumni VenturesBoutique Venture PartnersBrown and White VenturesPathway BioventuresUniversity System of Maryland Momentum FundAlexandria
Palm Therapeutics develops palmitoylation-targeted drugs using its proprietary PalmReader screening platform to identify novel therapeutic molecules.
BiotechDeep TechMedical Devices
Andrew Rudd(Cofounder & CEO)in
Peptilogics is a clinical-stage surgical therapeutics company developing zaloganan (PLG0206), a novel anti-biofilm drug to treat and prevent medical device-related infections such as prosthetic joint infections.
BiotechHealthtechMedical DevicesPittsburg, US
Jonathan Steckbeck(Founder)in
BoardStephan Dietrich(Director)in
Co-investorsAAF Management Ltd.Alpha Wave GlobalAMR Action FundBright Success CapitalMountain State CapitalNarya Capital+6 more
Scipher Medicine is a precision immunology company that combines molecular data from autoimmune patients, protein interaction mapping, and AI to match patients with the most effective therapy for immunological diseases.
AI & Machine LearningBiotechDigital Health
Joseph Loscalzo(Founder)Albert-László Barabási(Founder)
Co-investorsaMoonKhosla VenturesAlumni VenturesB3 HoldingCobalt VenturesEcho Health Ventures+2 more
Stylus Medicine develops in vivo genetic medicines using engineered recombinases, with initial focus on creating CAR-T therapies delivered via lipid nanoparticles for oncology, autoimmune, and genetic diseases.
BiotechDigital HealthMedical Devices
Michael C. Bassik, Ph.D.(Scientific Founder)Emile Nuwaysir, Ph.D.(Chairman & Chief Executive Officer)inJason Fontenot, Ph.D.(Chief Scientific Officer)Ami Bhatt(Founder)Lacramioara Bintu(Founder)Michael Bassik(Founder)
Co-investorsBrainstorm VenturesCAL InnovationCalifornia Innovation FundKhosla VenturesNeva Sgr.RA Capital+1 more
Valo builds an AI-driven drug discovery and development platform that combines real-world human data, causal inference, statistical genetics, and predictive chemistry to identify disease targets and engineer small-molecule compounds.
AI & Machine LearningBiotechDeep Tech
Co-investorsLifeforce Capital
Constellation Pharmaceuticals was a Cambridge, MA clinical-stage biopharmaceutical company developing epigenetics-based cancer therapies, including BET and EZH2 inhibitors.
BiotechHealthtech
Co-investorsClal Biotechnology IndustriesExSight VenturesLongitude CapitalThe Column Group
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ForkheadbioQuthero
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.